Track topics on Twitter Track topics that are important to you
Boston company creator PureTech Health already has one microbiome startup in its portfolio, Vedanta Biosciences. Today it’s unveiled a second one, Commense, with a different plan to harness the powe...
PureTech Health plc (LSE:PRTC) unveiled newco Commense Inc., which aims to develop therapeutic cocktails based on microbe combinations normally transferred to newborns through the birth canal to preve...
Boston-based Commense plans to develop microbial and nonmicrobial interventions aimed at improving child health.
Our East Coast drive started in New York this week, where we took a close look at the state of the city’s biotech ecosystem and the road ahead through the eyes of some of the area’s scientific ent...
Founding scientists and advisors named and exclusive worldwide license obtained to prevent and treat disease through microbiome-based interventions in early childhood C...
We have published hundreds of Commense news stories on BioPortfolio along with dozens of Commense Clinical Trials and PubMed Articles about Commense for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Commense Companies in our database. You can also find out about relevant Commense Drugs and Medications on this site too.